BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26022440)

  • 1. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines.
    Marzi A; Kercher L; Marceau J; York A; Callsion J; Gardner DJ; Geisbert TW; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S404-9. PubMed ID: 26022440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
    Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
    Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.
    Mire CE; Geisbert JB; Versteeg KM; Mamaeva N; Agans KN; Geisbert TW; Connor JH
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S384-8. PubMed ID: 25957964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
    Mire CE; Miller AD; Carville A; Westmoreland SV; Geisbert JB; Mansfield KG; Feldmann H; Hensley LE; Geisbert TW
    PLoS Negl Trop Dis; 2012; 6(3):e1567. PubMed ID: 22448291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
    Geisbert TW; Feldmann H
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
    Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
    J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filovirus infection of STAT-1 knockout mice.
    Raymond J; Bradfute S; Bray M
    J Infect Dis; 2011 Nov; 204 Suppl 3():S986-90. PubMed ID: 21987780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single shot against Ebola and Marburg virus.
    Baize S
    Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine research efforts for filoviruses.
    Hart MK
    Int J Parasitol; 2003 May; 33(5-6):583-95. PubMed ID: 12782057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.
    Saito T; Maruyama J; Nagata N; Isono M; Okuya K; Takadate Y; Kida Y; Miyamoto H; Mori-Kajihara A; Hattori T; Furuyama W; Ogawa S; Iida S; Takada A
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32842671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents.
    Warfield KL; Posten NA; Swenson DL; Olinger GG; Esposito D; Gillette WK; Hopkins RF; Costantino J; Panchal RG; Hartley JL; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S421-9. PubMed ID: 17940979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
    Geisbert TW; Strong JE; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad and Temperature Independent Replication Potential of Filoviruses on Cells Derived From Old and New World Bat Species.
    Miller MR; McMinn RJ; Misra V; Schountz T; Müller MA; Kurth A; Munster VJ
    J Infect Dis; 2016 Oct; 214(suppl 3):S297-S302. PubMed ID: 27354372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced antisense therapies for postexposure protection against lethal filovirus infections.
    Warren TK; Warfield KL; Wells J; Swenson DL; Donner KS; Van Tongeren SA; Garza NL; Dong L; Mourich DV; Crumley S; Nichols DK; Iversen PL; Bavari S
    Nat Med; 2010 Sep; 16(9):991-4. PubMed ID: 20729866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
    Jones SM; Feldmann H; Ströher U; Geisbert JB; Fernando L; Grolla A; Klenk HD; Sullivan NJ; Volchkov VE; Fritz EA; Daddario KM; Hensley LE; Jahrling PB; Geisbert TW
    Nat Med; 2005 Jul; 11(7):786-90. PubMed ID: 15937495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
    Woolsey C; Borisevich V; Agans KN; O'Toole R; Fenton KA; Harrison MB; Prasad AN; Deer DJ; Gerardi C; Morrison N; Cross RW; Eldridge JH; Matassov D; Geisbert TW
    J Infect Dis; 2023 Nov; 228(Suppl 7):S660-S670. PubMed ID: 37171813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of a small-molecule inhibitor of filovirus infection.
    Warren TK; Warfield KL; Wells J; Enterlein S; Smith M; Ruthel G; Yunus AS; Kinch MS; Goldblatt M; Aman MJ; Bavari S
    Antimicrob Agents Chemother; 2010 May; 54(5):2152-9. PubMed ID: 20211898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.
    Comer JE; Escaffre O; Neef N; Brasel T; Juelich TL; Smith JK; Smith J; Kalveram B; Perez DD; Massey S; Zhang L; Freiberg AN
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30717492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
    Mire CE; Matassov D; Geisbert JB; Latham TE; Agans KN; Xu R; Ota-Setlik A; Egan MA; Fenton KA; Clarke DK; Eldridge JH; Geisbert TW
    Nature; 2015 Apr; 520(7549):688-691. PubMed ID: 25853476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.